Table 3 Validation of the risk scoring system.
From: Development and Validation of a Risk Scoring System for Cephamycin-Associated Hemorrhagic Events
Predictor Variable | Risk Score | AUROC (95% CI) | |
|---|---|---|---|
Derivation | Validation | ||
Study antibiotics | |||
Reference¶ | 0 | 0.6169 (0.5918–0.6420) | 0.5953 (0.5610–0.6295) |
Cephamycins§ | 1 | ||
Chronic hepatic disease | |||
No | 0 | 0.5631 (0.5428–0.5833) | 0.5645 (0.5367–0.5924) |
Yes | 1 | ||
Age (years) | |||
<65 | 0 | 0.5718 (0.5463–0.5973) | 0.6000 (0.5677–0.6324) |
≥65 | 1 | ||
Bleeding tendency* | |||
No | 0 | 0.6581 (0.6321–0.6842) | 0.5967 (0.5628–0.6305) |
Yes | 2 | ||
History of bleeding ¥ | |||
No | 0 | 0.7097 (0.6837–0.7358) | 0.6839 (0.6495–0.7184) |
Yes | 4 | ||
Total score | 0~9 | 0.8035 (0.7794–0.8275) | 0.7550 (0.7198–0.7902) |
Hosmer-Lemeshow test | p = 0.1044 | p = 0.0641 | |
